McKesson Corporation (MCK)
McKesson (MCK) Outperforms Broader Market: What You Need to Know
In the closing of the recent trading day, McKesson (MCK) stood at $884.28, denoting a +1.37% move from the preceding trading day.
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet?
CAH's turnaround gains traction with strong earnings growth and margin expansion, outpacing MCK's steady performance outlook.
Here's Why You Should Add McKesson Stock to Your Portfolio Now
McKesson's strong oncology, GLP-1, and biopharma growth fuel earnings momentum, but margin pressure and segment volatility remain key watch points.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Ameriprise Financial Inc. Has $442.37 Million Stock Holdings in McKesson Corporation $MCK
Ameriprise Financial Inc. lifted its stake in shares of McKesson Corporation (NYSE: MCK) by 33.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 572,569 shares of the company's stock after acquiring an additional 144,869 shares during the quarter. Ameriprise
8 Knots Management LLC Acquires New Holdings in McKesson Corporation $MCK
8 Knots Management LLC bought a new stake in McKesson Corporation (NYSE: MCK) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 17,596 shares of the company's stock, valued at approximately $13,594,000. McKesson comprises approximately 1.5% of 8 Knots
Benchmark Investment Advisors LLC Makes New $468,000 Investment in McKesson Corporation $MCK
Benchmark Investment Advisors LLC purchased a new stake in McKesson Corporation (NYSE: MCK) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 605 shares of the company's stock, valued at approximately $468,000. Other large investors have also added to or reduced their stakes
Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
McKesson Corporation (MCK) Presents at Leerink Global Healthcare Conference 2026 Transcript
McKesson Corporation (MCK) Presents at Leerink Global Healthcare Conference 2026 Transcript
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson Corporation: Strong Q3 Earnings But Upside Exhausted
McKesson Corporation shares are now fairly valued after a 16% price increase, prompting a Hold rating. Strong Q3 results were driven by 11% revenue growth and a 37% surge in the Oncology & Multispeciality segment, aided by M&A. Management raised FY2026 guidance, with EPS now expected at $38.80–39.20 and revenue growth at 12–16%.
